Papers
Topics
Authors
Recent
Gemini 2.5 Flash
Gemini 2.5 Flash
167 tokens/sec
GPT-4o
7 tokens/sec
Gemini 2.5 Pro Pro
42 tokens/sec
o3 Pro
4 tokens/sec
GPT-4.1 Pro
38 tokens/sec
DeepSeek R1 via Azure Pro
28 tokens/sec
2000 character limit reached

Predicting Parkinson's disease evolution using deep learning (2312.17290v2)

Published 28 Dec 2023 in eess.IV and cs.CV

Abstract: Parkinson's disease is a neurological condition that occurs in nearly 1% of the world's population. The disease is manifested by a drop in dopamine production, symptoms are cognitive and behavioural and include a wide range of personality changes, depressive disorders, memory problems, and emotional dysregulation, which can occur as the disease progresses. Early diagnosis and accurate staging of the disease are essential to apply the appropriate therapeutic approaches to slow cognitive and motor decline. Currently, there is not a single blood test or biomarker available to diagnose Parkinson's disease. Magnetic resonance imaging has been used for the past three decades to diagnose and distinguish between PD and other neurological conditions. However, in recent years new possibilities have arisen: several AI algorithms have been developed to increase the precision and accuracy of differential diagnosis of PD at an early stage. To our knowledge, no AI tools have been designed to identify the stage of progression. This paper aims to fill this gap. Using the "Parkinson's Progression Markers Initiative" dataset, which reports the patient's MRI and an indication of the disease stage, we developed a model to identify the level of progression. The images and the associated scores were used for training and assessing different deep-learning models. Our analysis distinguished four distinct disease progression levels based on a standard scale (Hoehn and Yah scale). The final architecture consists of the cascading of a 3DCNN network, adopted to reduce and extract the spatial characteristics of the RMI for efficient training of the successive LSTM layers, aiming at modelling the temporal dependencies among the data. Our results show that the proposed 3DCNN + LSTM model achieves state-of-the-art results by classifying the elements with 91.90\% as macro averaged OVR AUC on four classes

Definition Search Book Streamline Icon: https://streamlinehq.com
References (86)
  1. Joint feature-sample selection and robust diagnosis of parkinson’s disease from mri data. NeuroImage, 141:206–219, 2016.
  2. Classification of smri for ad diagnosis with convolutional neuronal networks: A pilot 2-d+ \\\backslash\epsilonstudy on adni. In International Conference on Multimedia Modeling, pages 690–701. Springer, 2017.
  3. Classification of brain tumors from mri images using a convolutional neural network. Applied Sciences, 10(6):1999, 2020.
  4. Identifying the best machine learning algorithms for brain tumor segmentation, progression assessment, and overall survival prediction in the brats challenge. arXiv preprint arXiv:1811.02629, 2018.
  5. R. Balestrino and A. Schapira. Parkinson disease. European journal of neurology, 27(1):27–42, 2020.
  6. A. Berger and S. Guda. Threshold optimization for f measure of macro-averaged precision and recall. Pattern Recognition, 102:107250, 2020.
  7. Parkinson’s disease: Hoehn and yahr scale. Movement disorders: a video atlas: a video atlas, pages 4–5, 2012.
  8. Diagnosis of parkinson’s disease from electroencephalography signals using linear and self-similarity features. Expert Systems, 39(7):e12472, 2022.
  9. N. Bolas. Basic mri principles. Equine MRI, pages 1–37, 2010.
  10. H. Braak and E. Braak. Pathoanatomy of parkinson’s disease. Journal of neurology, 247:II3–II10, 2000.
  11. V. Bui and A. Alaei. Virtual reality in training artificial intelligence-based systems: a case study of fall detection. Multimedia Tools and Applications, pages 1–18, 2022.
  12. Progression marker of parkinson’s disease: a 4-year multi-site imaging study. Brain, 140(8):2183–2192, 2017.
  13. Objective and automatic classification of parkinson disease with leap motion controller. Biomedical engineering online, 17(1):1–21, 2018.
  14. Gating creates slow modes and controls phase-space complexity in grus and lstms. In Mathematical and Scientific Machine Learning, pages 476–511. PMLR, 2020.
  15. A review of medical image data augmentation techniques for deep learning applications. Journal of Medical Imaging and Radiation Oncology, 65(5):545–563, 2021.
  16. Age-related decreases in nurr1 immunoreactivity in the human substantia nigra. Journal of Comparative Neurology, 450(3):203–214, 2002.
  17. Deep brain stimulation for psychiatric disorders: where we are now. Neurosurgical focus, 38(6):E2, 2015.
  18. Identification and prediction of parkinson’s disease subtypes and progression using machine learning in two cohorts. npj Parkinson’s Disease, 8(1):172, 2022.
  19. Parkinson’s disease: the psychological aspects of a chronic illness. Psychological Bulletin, 99(3):375, 1986.
  20. Evaluation of three methods for mri brain tumor segmentation. In 2011 eighth international conference on information technology: new generations, pages 494–499. IEEE, 2011.
  21. Early-onset vs. late-onset parkinson’s disease: A clinical-pathological study. Canadian journal of neurological sciences, 43(1):113–119, 2016.
  22. Machine learning models for parkinson’s disease detection and stage classification based on spatial-temporal gait parameters. Gait & Posture, 98:49–55, 2022.
  23. Processing pipeline for image reconstructed fnirs analysis using both mri templates and individual anatomy. Neurophotonics, 8(2):025010, 2021.
  24. M. Frasca and G. Tortora. Visualizing correlations among parkinson biomedical data through information retrieval and machine learning techniques. Multimedia Tools and Applications, 81(11):14685–14703, 2022.
  25. Y. Gao and D. Glowacka. Deep gate recurrent neural network. In Asian conference on machine learning, pages 350–365. PMLR, 2016.
  26. Determining the severity of parkinson’s disease in patients using a multi task neural network. Multimedia Tools and Applications, pages 1–16, 2023.
  27. Nipype: a flexible, lightweight and extensible neuroimaging data processing framework in python. Frontiers in neuroinformatics, page 13, 2011.
  28. D. N. Greve and B. Fischl. Accurate and robust brain image alignment using boundary-based registration. Neuroimage, 48(1):63–72, 2009.
  29. Dynamic hand gesture recognition using 3dcnn and lstm with fsm context-aware model. Sensors, 19(24):5429, 2019.
  30. A comprehensive study of data augmentation strategies for prostate cancer detection in diffusion-weighted mri using convolutional neural networks. Journal of Digital Imaging, 34(4):862–876, 2021.
  31. A timeline for parkinson’s disease. Parkinsonism & related disorders, 16(2):79–84, 2010.
  32. Db-lstm: Densely-connected bi-directional lstm for human action recognition. Neurocomputing, 444:319–331, 2021.
  33. Magnetic resonance imaging for the diagnosis of parkinson’s disease. Journal of neural transmission, 124(8):915–964, 2017.
  34. Parkinsonism: onset, progression, and mortality. Neurology, 17(5):427–427, 1967.
  35. Automatic quantification of white matter hyperintensities on t2-weighted fluid attenuated inversion recovery magnetic resonance imaging. Magnetic Resonance Imaging, 85:71–79, 2022.
  36. K. Inthavong et al. List of useful computational software. Clinical and Biomedical Engineering in the Human Nose, page 301, 2021.
  37. D. K. Jones and M. Cercignani. Twenty-five pitfalls in the analysis of diffusion mri data. NMR in Biomedicine, 23(7):803–820, 2010.
  38. A. Kharb and P. Chaudhary. A review on skull stripping techniques of brain mri images. Webology (ISSN: 1735-188X), 18(6), 2021.
  39. R. Khaskhoussy and Y. B. Ayed. Improving parkinson’s disease recognition through voice analysis using deep learning. Pattern Recognition Letters, 2023.
  40. B. M. Kinney and P. Lozanova. High intensity focused electromagnetic therapy evaluated by magnetic resonance imaging: Safety and efficacy study of a dual tissue effect based non-invasive abdominal body shaping. Lasers in surgery and medicine, 51(1):40–46, 2019.
  41. Parkinson’s disease: etiology, neuropathology, and pathogenesis. Exon Publications, pages 3–26, 2018.
  42. N. Kriegeskorte and T. Golan. Neural network models and deep learning. Current Biology, 29(7):R231–R236, 2019.
  43. Expression invariant face recognition based on multi-level feature fusion and transfer learning technique. Multimedia Tools and Applications, pages 1–19, 2022.
  44. Moving beyond processing and analysis-related variation in neuroscience. BioRxiv, 2021.
  45. A 3d convolutional neural network for volumetric image semantic segmentation. Procedia Manufacturing, 39:422–428, 2019.
  46. Current understanding of the molecular mechanisms in parkinson’s disease: Targets for potential treatments. Translational neurodegeneration, 6(1):1–35, 2017.
  47. V. Mani and S. Arivazhagan. Survey of medical image registration. Journal of Biomedical Engineering and Technology, 1(2):8–25, 2013.
  48. The parkinson progression marker initiative (ppmi). Progress in neurobiology, 95(4):629–635, 2011.
  49. An mri-based deep learning approach for accurate detection of alzheimer’s disease. Alexandria Engineering Journal, 2022.
  50. Deep learning-based parkinson disease classification using pet scan imaging data. In 2021 IEEE 6th International Conference on Computing, Communication and Automation (ICCCA), pages 837–841. IEEE, 2021.
  51. Data augmentation via image registration. In 2019 IEEE international conference on image processing (ICIP), pages 4250–4254. IEEE, 2019.
  52. Diagnosis and initial management of parkinson’s disease. New England Journal of Medicine, 353(10):1021–1027, 2005.
  53. A general skull stripping of multiparametric brain mris using 3d convolutional neural network. Scientific Reports, 12(1):1–11, 2022.
  54. A multilevel-roi-features-based machine learning method for detection of morphometric biomarkers in parkinson’s disease. Neuroscience letters, 651:88–94, 2017.
  55. W. Poewe. Non-motor symptoms in parkinson’s disease. European journal of neurology, 15:14–20, 2008.
  56. High-accuracy classification of parkinson’s disease through shape analysis and surface fitting in 123i-ioflupane spect imaging. IEEE journal of biomedical and health informatics, 21(3):794–802, 2016.
  57. Environmental risk factors and parkinson’s disease: a metaanalysis. Environmental research, 86(2):122–127, 2001.
  58. M. Rafało. Cross validation methods: analysis based on diagnostics of thyroid cancer metastasis. ICT Express, 8(2):183–188, 2022.
  59. Ensemble of deep transfer learning models for parkinson’s disease classification. In Soft Computing and Signal Processing, pages 135–143. Springer, 2022.
  60. Segmentation of brain tumor using deep learning methods: A review. In Proceedings of the International Conference on Data Science, Machine Learning and Artificial Intelligence, pages 209–215, 2021.
  61. T. Rejusha and V. K. KS. Artificial mri image generation using deep convolutional gan and its comparison with other augmentation methods. In 2021 international conference on communication, Control and Information Sciences (ICCISc), volume 1, pages 1–6. IEEE, 2021.
  62. S. Rewar. A systematic review on parkinson’s disease (pd). Indian Journal of Research in Pharmacy and Biotechnology, 3(2):176, 2015.
  63. Handwriting as an objective tool for parkinson’s disease diagnosis. Journal of neurology, 260:2357–2361, 2013.
  64. A comparative analysis of data augmentation approaches for magnetic resonance imaging (mri) scan images of brain tumor. Acta informatica medica, 28(1):29, 2020.
  65. Multi-grade brain tumor classification using deep cnn with extensive data augmentation. Journal of computational science, 30:174–182, 2019.
  66. A systematic review of artificial intelligence (ai) based approaches for the diagnosis of parkinson’s disease. Archives of Computational Methods in Engineering, 29(6):3639–3653, 2022.
  67. Dopamine deficiency in the cerebral cortex in parkinson disease. Neurology, 32(9):1039–1039, 1982.
  68. Discovery of parkinson’s disease states and disease progression modelling: a longitudinal data study using machine learning. The Lancet Digital Health, 3(9):e555–e564, 2021.
  69. A deep learning approach for prediction of parkinson’s disease progression. Biomedical Engineering Letters, 10(2):227–239, 2020.
  70. Automated classification of parkinson’s disease using diffusion tensor imaging data. In International Symposium on Visual Computing, pages 658–669. Springer, 2020.
  71. A. Shewalkar. Performance evaluation of deep neural networks applied to speech recognition: Rnn, lstm and gru. Journal of Artificial Intelligence and Soft Computing Research, 9(4):235–245, 2019.
  72. 3d deep learning on medical images: a review. Sensors, 20(18):5097, 2020.
  73. S. M. Smith. Bet: Brain extraction tool. FMRIB TR00SMS2b, Oxford Centre for Functional Magnetic Resonance Imaging of the Brain), Department of Clinical Neurology, Oxford University, John Radcliffe Hospital, Headington, UK, 2000.
  74. S. C. Strother. Evaluating fmri preprocessing pipelines. IEEE Engineering in Medicine and Biology Magazine, 25(2):27–41, 2006.
  75. Classification of parkinson’s disease and its stages using machine learning. Scientific Reports, 12(1):14036, 2022.
  76. Bradley j. robottom, william j. weiner, and lisa m. shulman. International Neurology: A Clinical Approach, page 152, 2011.
  77. Cross-validation and permutations in mvpa: Validity of permutation strategies and power of cross-validation schemes. NeuroImage, 238:118145, 2021.
  78. Parkinson’s disease classification from magnetic resonance images (mri) using deep transfer learned convolutional neural networks. In 2021 IEEE 18th India Council International Conference (INDICON), pages 1–6. IEEE, 2021.
  79. Deep learning-based scheme to diagnose parkinson’s disease. Expert Systems, 39(3):e12739, 2022.
  80. Classification of parkinson’s disease gait using spatial-temporal gait features. IEEE journal of biomedical and health informatics, 19(6):1794–1802, 2015.
  81. K. Wakabayashi. Where and how alpha-synuclein pathology spreads in parkinson’s disease. Neuropathology, 40(5):415–425, 2020.
  82. Deep learning approach to parkinson’s disease detection using voice recordings and convolutional neural network dedicated to image classification. In 2019 41st Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), pages 717–720. IEEE, 2019.
  83. J. You and J. Korhonen. Deep neural networks for no-reference video quality assessment. In 2019 IEEE International Conference on Image Processing (ICIP), pages 2349–2353. IEEE, 2019.
  84. Differentiating patients with parkinson’s disease from normal controls using gray matter in the cerebellum. The Cerebellum, 16(1):151–157, 2017.
  85. Explainable ai: classification of mri brain scans orders for quality improvement. In Proceedings of the 6th IEEE/ACM International Conference on Big Data Computing, Applications and Technologies, pages 95–102, 2019.
  86. Learning spatiotemporal features using 3dcnn and convolutional lstm for gesture recognition. In Proceedings of the IEEE International Conference on Computer Vision Workshops, pages 3120–3128, 2017.

Summary

We haven't generated a summary for this paper yet.

Ai Sparkles Streamline Icon: https://streamlinehq.com Summarize Now
Youtube Logo Streamline Icon: https://streamlinehq.com

YouTube